CANADIAN DIABETES ASSOCIATION 2013 CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION AND MANAGEMENT OF DIABETES IN CANADA DUALITY OF INTEREST DISCLOSURES EXECUTIVE, STEERING - Dipeptidyl peptidase - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-04-24 07:17:09 Eli Lilly and Company Dipeptidyl peptidase-4 inhibitor Novo Nordisk Sanofi Technology Pharmaceutics Pharmaceutical Research and Manufacturers of America Pharmaceutical industry in the United Kingdom Pharmaceutical industry Healthcare in India Pharmaceutical industry in India		CANADIAN DIABETES ASSOCIATION 2013 CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION AND MANAGEMENT OF DIABETES IN CANADA DUALITY OF INTEREST DISCLOSURES EXECUTIVE, STEERING & EXPERT COMMITTEES Add to Reading List Source URL: guidelines.diabetes.ca Download Document from Source Website File Size: 178,46 KB Share Document on Facebook

	House of Commons Health Committee The Influence of the Pharmaceutical Industry DocID: 1v3YA - View Document
	Speakers Confirmed BD Biosciences Industry Days A roadshow of talks specifically tailored to those working in the biotechnology, clinical research and pharmaceutical industry. Join leaders in the field and BD experts for DocID: 1uWLK - View Document
	NEWS RELEASE Copley Scientific celebrates seven decades of responsive service to the pharmaceutical industry 17th May 2016: Nottingham, UK: Copley Scientific, a family-owned company that began supplying glassware to the DocID: 1utWK - View Document
	2nd APV Conference on “Highly Potent Drug Products in the Pharmaceutical Industry” 26 to 27 September 2018 Mannheim, Germany DocID: 1utU5 - View Document
	Index of abbreviations AAMC – Australian Army Medical Corps AB – Artium Baccalaureus, Bachelor of Arts Aberd – Aberdeen ABPI – Association of the British Pharmaceutical Industry AC – Companion, Order of Austral DocID: 1ushC - View Document